p53 tumor suppressor gene: At the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment

Annals of the New York Academy of Sciences

Volumn 919, Issue , 2000, Pages 79-85

  Perwez Hussain, S ^a   Hollstein, Monica H ^b   Harris, Curtis C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B; PROTEIN P53;

CANCER; CANCER RISK; CARCINOGENESIS; CONFERENCE PAPER; GENE EXPRESSION; GENE MUTATION; HEPATITIS B VIRUS; HUMAN; LIVER CANCER; RISK ASSESSMENT; TUMOR SUPPRESSOR GENE;

HEPATITIS B VIRUS;

EID: 0033695273     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06870.x     Document Type: Conference Paper

References (57)

1. Chemical and physical carcinogenesis: Advances and perspectives
2. p53 mutations in human cancers
3. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
4. Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies
5. Molecular epidemiology of human cancer: Contribution of mutation spectra studies of tumor suppressor genes
6. Characteristic p53 mutations correlate with inducible NO synthase expression in human colorectal cancer
7. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase (NOS2) expression by wild-type p53
8. Upregulation of NOS2 expression in cancer-prone p53 knockout mice
9. p53 and vascular endothelial growth factor regulate tumour growth of NOS2-expressing human carcinoma cells
10. p53 mutations in lung cancers from non-smoking atomic-bomb survivors
11. Gender comparisons in human lung cancer: Analysis of p53 mutations, anti-p53 serum antibodies, and C-erbB-2 expression
12. DNA strand bias in the repair of the p53 gene in normal human and xeroderma pigmentosum group C fibroblasts
13. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3
14. p53 modulation of TFIIH-associated nucleotide excision repair activity
15. The XPB and XPD helicases are components of the p53-mediated apoptosis pathway
16. Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners
17. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis
18. Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro
19. Genetic basis for p53 overexpression in human breast cancer
20. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus
21. Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas
22. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung
23. Mutational hot spot in the p53 gene in human hepatocellular carcinomas
24. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
25. p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China
26. Aberrations of p53 gene in human hepatocellular carcinoma from China
27. An aflatoxin-associated mutational hot spot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico
28. Aflatoxin B1 induces the transversion of G→T in codon 249 of the p53 tumor suppressor gene in human hepatocytes
29. Aflatoxin B1 induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines
30. Geographic variation of p53 mutational profile in nonmalignant human liver
31. Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity, but has no effect on transforming growth factor beta 1-mediated apoptosis
32. Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent
33. Genetic heterogeneity of hepatocellular carcinoma
34. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma
35. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions
36. The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells
37. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator
38. Transcriptional trans-activating function of hepatitis B virus
39. Trans-activation of viral enhancers by the hepatitis B virus X protein
40. A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA
41. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis
42. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade
43. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA
44. Functional inactivation, but not structural mutation of p53 causes liver cancer
45. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene
46. Hepatitis B virus X protein inhibits nucleotide excision repair
47. Instability of integrated hepatitis B virus DNA with inverted repeat structure in a transgenic mouse
48. Evidence for increased in vitro recombination with insertion of human hepatitis B virus DNA
49. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma
50. Sunburn and p53 in the onset of skin cancer
51. p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers
52. Clinical implications of the p53 tumor-suppressor gene
53. Molecular epidemiology and the genetics of environmental cancer
54. Environment and cancer: Who are susceptible?
55. Genetic testing for cancer risk
56. The environment and disease: Association or causation